CAD 13.09
(5.99%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Operating Expenses | 48.98 Million | 34.41 Million | 7.71 Million | 5.26 Million | 5.29 Million |
Selling, General and Administrative Expenses | 44.37 Million | 5.49 Million | 2.05 Million | 1.95 Million | 5.14 Million |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | - | -285.91 Thousand | -77.59 Thousand | -61.3 Thousand | - |
Cost and Expenses | 48.98 Million | 34.41 Million | 7.71 Million | 5.26 Million | 5.29 Million |
Operating Income | -48.98 Million | -34.41 Million | -7.71 Million | -6.08 Million | -5.3 Million |
Interest Expense | 71.38 Thousand | 50.3 Thousand | 136.43 Thousand | 26.23 Thousand | - |
Income Tax Expense | - | -235.61 Thousand | 58.84 Thousand | -35.07 Thousand | - |
Earnings before Tax | -37.71 Million | -32.41 Million | -5.45 Million | -5.89 Million | -5.3 Million |
Net Income | -37.71 Million | -32.41 Million | -5.45 Million | -5.89 Million | -5.3 Million |
Earnings Per Share Basic | -0.21 | -0.20 | -0.04 | -0.05 | -0.04 |
Earnings Per Share Diluted | -0.21 | -0.20 | -0.04 | -0.05 | -0.04 |
Weighted Average Shares Outstanding | 178 Million | 159.62 Million | 130.09 Million | 124.79 Million | 124.79 Million |
Weighted Average Shares Outstanding (Diluted) | 178 Million | 159.62 Million | 130.09 Million | 124.79 Million | 124.79 Million |
Gross Margin | - | - | - | - | - |
EBIT Margin | - | - | - | - | - |
Profit Margin | - | - | - | - | - |
EBITDA | -47.19 Million | -34.44 Million | -7.76 Million | -5.31 Million | -5.29 Million |
Earnings Before Tax Margin | - | - | - | - | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 9.79 Million | 24.37 Million | 11.71 Million | 48.98 Million | 8.67 Million | 12.11 Million |
Selling, General and Administrative Expenses | 1.97 Million | 1.85 Million | 1.87 Million | - | 4.2 Million | 1.17 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 543.00 | - | -124.99 Thousand | -124.77 Thousand | - | 214.00 |
Cost and Expenses | 9.79 Million | 24.37 Million | 11.71 Million | 48.98 Million | 8.67 Million | 12.11 Million |
Operating Income | -9.79 Million | 24.37 Million | -11.71 Million | -48.98 Million | -8.67 Million | -12.11 Million |
Interest Expense | 13.55 Thousand | 13.39 Thousand | 12.88 Thousand | 71.38 Thousand | 19.54 Thousand | 19.3 Thousand |
Income Tax Expense | 14.09 Thousand | 13.39 Thousand | -112.1 Thousand | -53.39 Thousand | 19.54 Thousand | 19.52 Thousand |
Earnings before Tax | -7.57 Million | -19.74 Million | -8.61 Million | -37.71 Million | -4.21 Million | -9.71 Million |
Net Income | -7.57 Million | -19.74 Million | -8.61 Million | -37.71 Million | -4.21 Million | -9.71 Million |
Earnings Per Share Basic | -0.04 | -0.11 | -0.05 | - | -0.02 | -0.06 |
Earnings Per Share Diluted | -0.04 | -0.11 | -0.05 | - | -0.02 | -0.06 |
Weighted Average Shares Outstanding | 188.15 Million | 187.57 Million | 186.76 Million | 178 Million | 180.29 Million | 172.73 Million |
Weighted Average Shares Outstanding (Diluted) | 188.15 Million | 187.57 Million | 186.75 Million | 178 Million | 180.29 Million | 172.73 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -9.12 Million | -23.48 Million | -10.81 Million | - | -7.99 Million | -11.94 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
300232
PCHM
AIRJW
300252
NMHI
BMED